← All trials
NCT02897180
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 10, 2017
- Primary completion
- Oct 1, 2020
- Completion date
- Mar 1, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 3300
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Badalona Hospital Germans Trias i PujolLead sponsor
- Badalona Hospital Germans Trias i PujolOverall official - principal investigator
- National Center for Tuberculosis and Lung Diseases, GeorgiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.